TABLE 3.
Outcomes of uncovered self‐expandable metal stent placement for distal biliary obstruction due to non‐pancreatic cancer.
UCSEMS | |
---|---|
n = 32 | |
Technical success, n (%) | 32 (100) |
Clinical success, n (%) | 32 (100) |
Median time to RBO (range), days | 140 (6–744) |
RBO, n (%) | 14 (35) |
Causes of RBO, n (%) | |
Ingrowth | 8 (25) |
Overgrowth | 0 |
Sludge | 6 (18.8) |
Migration | 0 |
Adverse events other than RBO, n (%) | 2 (6.3) |
Early (≤30 days) | 2 (6.3) |
Pancreatitis | 1 (3.1) |
Cholecystitis | 1 (3.1) |
Cholangitis | 0 |
Late (>30 days) | 0 |
Abbreviations: RBO, recurrent biliary obstruction; UCSEMS, uncovered self‐expandable metal stents.